Cancer Detection Blood Tests in Leicester

It is now estimated for patients born after 1960, 1 in 2 will be diagnosed with cancer in their lifetime, with over half of those diagnosed after the cancer has spread.

Finding cancer early can significantly improve outcomes.

At The Health Suite Leicester, we offer cutting-edge blood tests for early cancer detection.

Cancer Detection Blood Tests

The Health Suite Leicester offers two tests as part of our cancer dietitian service: the Trucheck Intelli and the Trucheck FemmeSafe. We understand how worried and anxious you might feel and are here to help. We provide many same-day appointments, and in many cases, results are also available on the same day, giving you the answers you need as quickly as possible.

1. Trucheck Intelli

1 in 2 people in the UK, born after 1960, will be diagnosed with cancer in their lifetime.
Currently, almost half of those people are diagnosed after the cancer has spread.

The test can help avoid late cancer detection which can lead to intensive and expensive treatments. Finding cancer early, before you have symptoms, can significantly improve your chances of survival.

Trucheck Intelli can find over 70 types of solid organ cancers. It is a simple revolutionary blood test which can help you find cancer early before you show symptoms. It detects common cancers such as Breast, Lung, Bowel, Prostate, and many other cancers which are not routinely screened for. It is designed to be used in addition to and not replace existing cancer screening.

These cancers account for 81% of all cancer cases globally and include several types of aggressive cancer.

Criteria for suitability :

• Women and men above 40 years of age, who have never been diagnosed with any cancer.
• Asymptomatic at present
• No prior history of diagnosis or treatment of any cancer
• No clinical or radiological suspicion of cancer at present

How does it work?

• When cancer is present in someone, it sheds tiny cells and tumour fragments into the bloodstream, called circulating tumour cells (CTCs).
• These cells are the main reason cancer eventually spreads in the body, especially if they move in clusters (a group).
• Trucheck can detect them from your blood sample and indicate the likely organ of origin.
• Healthcare professionals can then carry out targeted follow-up investigations and treat patients if necessary.
• Results take 2 weeks to come back.

2. Trucheck FemmeSafe

• Cervical Cancer: Is the 14th most common cancer in the UK in females, with 3200 new cases every year. 1 in 142 females will get it in their lifetime. Risk factors include smoking, oral contraceptive pill use, HPV infection, and multiple sexual partners. It is more commonly diagnosed in women under the age of 45.
• Endometrial Cancer: Is the most common gynaecological cancer in the UK, with 1 in 36 females affected over their lifetime. Each year there are approximately 9700 new cases. Rates of this cancer have been increasing and more commonly affect females aged over 50 years, highest in those aged 75-79
• Ovarian Cancer: Ovarian cancer is the 6th most common cancer in females, with approximately 7500 new cases every year, it is more common in older females and will affect 1 in 50 females over their lifetime. Survival rates with treatment have doubled in the last 50 years.
• Breast Cancer: 1 in 7 women will develop breast cancer in their lifetime. With over 55,000 new cases every year. Early diagnosis when breast cancer is localised can significantly improve the chances of survival. Risk factors for breast cancer include HRT, oral contraceptive pills, being overweight or obese, excessive alcohol and not breastfeeding.

FemmeSafe can detect the top 4 cancers for women at early stages: Cervical, Endometrial, Ovarian & Breast

Criteria for suitability:

• Women who have missed their recommended smear test or screening mammogram
• Asymptomatic at present
• All women above 40 years of age
• No prior history of diagnosis or treatment of any cancer
• No clinical or radiological suspicion of cancer at present

Exclusion criteria for all tests listed above

• Patient with any cancer at present or in past (solid organ or haematolymphoid)
• Patient in remission after treatment completion
• One cancer is being monitored but the patient/doctor wants to rule out other solid organ cancers.
• Diagnosed benign condition with intent to rule out cancer.
• Any suspected cancer, clinically or radiologically
• Blood transfusion in the last 72 hours before blood draw for TrucheckTM

What is the Process?

You will require an initial 15-minute consultation with a doctor to ensure you are suitable for the test and to answer any questions you may have. Following this you can book in for the blood test if you are suitable. If you are found not to be suitable the cost of this appointment is non-refundable.